サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1279668

糖尿病管理における人工知能の世界市場規模調査＆予測、タイプ別、用途別、地域別分析、2022-2029年

Global Artificial Intelligence in Diabetes Management Market Size study & Forecast, by Type, by Application and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
糖尿病管理における人工知能の世界市場規模調査＆予測、タイプ別、用途別、地域別分析、2022-2029年
出版日: 2023年05月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖尿病管理における人工知能（AI）とは、糖尿病の管理・治療を支援するために、機械学習アルゴリズムなどの高度なコンピューティング技術を利用することを指します。

糖尿病管理におけるAIの目標は、患者が血糖値をより効果的に監視・管理し、合併症のリスクを低減し、全体的なQOLを向上させることにあります。糖尿病管理における人工知能（AI）世界市場の主な促進要因は、糖尿病の有病率の増加、AIと機械学習の進歩、個別化医療への需要の増加です。さらに、ウェアラブルデバイスの採用が進み、AIと機械学習の進歩が高まっていることが、予測期間2022-2029年にかけて、市場に有利な成長機会を生み出しています。

アフリカでは、国際糖尿病連合（IDF）の推計によると、2019年の糖尿病患者数は1,940万人であり、この数は2045年までに4,700万人に増加すると予想されています。（出典：IDF Diabetes Atlas, Ninth edition, 2019）。同様に、東南アジアでは、IDFは2019年に8,800万人の糖尿病患者がいたと推定し、この数は2045年までに1億5,300万人に増加すると予想されています。（出典：IDF Diabetes Atlas, Ninth edition, 2019）。これとともに、西太平洋地域では、IDFは2019年に1億5,900万人の糖尿病患者が存在し、この数は2045年までに2億1,400万人に増加すると予測しています。（出典：IDF Diabetes Atlas, Ninth edition, 2019）。しかし、糖尿病管理における人工知能（AI）の高コストが、2022年から2029年の予測期間を通じて市場成長を阻害しています。

糖尿病管理における人工知能（AI）の世界市場調査において考慮される主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界のその他の地域です。北米市場は、糖尿病管理におけるAIの最大市場であり、主にこの地域における糖尿病の高い有病率、高度なヘルスケアインフラの利用、デジタル技術の採用がその要因となっています。北米では米国が最大の市場であり、カナダがそれに続いています。糖尿病管理におけるAIのアジア太平洋市場は、糖尿病の高い有病率、医療費の増加、デジタル技術の採用拡大などの要因によって、著しい成長が見込まれています。アジア太平洋地域では、中国、インド、日本が主要な市場となっています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2019年～2029年
    • 糖尿病管理における人工知能（AI）市場、地域別、2019年～2029年
    • 糖尿病管理における人工知能（AI）市場：タイプ別、2019年～2029年
    • 糖尿病管理における人工知能（AI）市場：用途別、2019年～2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 糖尿病管理における人工知能（AI）の世界市場定義と範囲

  • 本調査の目的
  • 市場の定義と範囲
    • 本調査の範囲
    • 産業の進化
  • 本調査で考慮した年数
  • 通貨換算レート

第3章 糖尿病管理における人工知能（AI）の世界市場力学

  • 糖尿病管理における人工知能（AI）市場の影響分析（2019年～2029年）
    • 市場促進要因
      • 糖尿病の有病率の増加
      • AIと機械学習の進歩
      • パーソナライズドヘルスケアへの需要の高まり
    • 市場の課題
      • 糖尿病管理における人工知能（AI）の高コスト化
    • 市場の機会
      • ウェアラブルデバイスの採用拡大
      • AIと機械学習の進歩

第4章 糖尿病管理における人工知能（AI）市場の世界の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップクラスの投資機会
  • 主要成功戦略

第5章 リスクアセスメント：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 糖尿病管理における人工知能（AI）の世界市場：タイプ別

  • 市場スナップショット
  • 糖尿病管理における人工知能（AI）の世界市場：タイプ別、実績 - ポテンシャル分析
  • 糖尿病管理における人工知能（AI）の世界市場タイプ別、推定・予測2019-2029
  • 糖尿病管理における人工知能（AI）市場、サブセグメント別分析
    • ケースベースの推論
    • インテリジェントなデータ分析

第7章 糖尿病管理における人工知能（AI）の世界市場：用途別

  • 市場スナップショット
  • 糖尿病管理における人工知能（AI）の世界市場：用途別、実績 - ポテンシャル分析
  • 糖尿病管理における人工知能（AI）の世界市場推定・予測（用途別）：2019年～2029年
  • 糖尿病管理における人工知能（AI）市場、サブセグメント別分析
    • グルコースモニタリングデバイス
    • 診断用デバイス
    • インスリンデリバリーデバイス
    • その他のデバイス

第8章 糖尿病管理における人工知能（AI）市場の世界市場：地域別分析

  • 糖尿病管理における人工知能（AI）市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • アプリケーション別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の糖尿病管理における人工知能（AI）市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の糖尿病管理における人工知能（AI）市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの糖尿病管理における人工知能（AI）市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Medtronic
    • Dexcom
    • Glooko
    • Diabeloop
    • Bigfoot Biomedical
    • Beta Bionics
    • One Drop
    • Diabnext
    • Tidepool

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Artificial Intelligence (AI) in Diabetes Management Market, report scope
  • TABLE 2. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 70. List of primary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Artificial Intelligence (AI) in Diabetes Management Market, research methodology
  • FIG 2. Global Artificial Intelligence (AI) in Diabetes Management Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Artificial Intelligence (AI) in Diabetes Management Market, key trends 2021
  • FIG 5. Global Artificial Intelligence (AI) in Diabetes Management Market, growth prospects 2022-2029
  • FIG 6. Global Artificial Intelligence (AI) in Diabetes Management Market, porters 5 force model
  • FIG 7. Global Artificial Intelligence (AI) in Diabetes Management Market, pest analysis
  • FIG 8. Global Artificial Intelligence (AI) in Diabetes Management Market, value chain analysis
  • FIG 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Artificial Intelligence (AI) in Diabetes Management Market, regional snapshot 2019 & 2029
  • FIG 15. North America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Artificial Intelligence (AI) in Diabetes Management Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Artificial Intelligence (AI) in Diabetes Management Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Artificial Intelligence (AI) in diabetes management refers to the use of advanced computing technologies, such as machine learning algorithms, to assist in the management and treatment of diabetes. The goal of AI in diabetes management is to help patients monitor and manage their blood sugar levels more effectively, reduce the risk of complications, and improve their overall quality of life. The major driving factors for the Global Artificial Intelligence (AI) in Diabetes Management Market are growing prevalence of diabetes, advancements in AI and machine learning and increasing demand for personalized healthcare. Moreover, growing adoption of wearable devices and rising advancements in AI and machine learning is creating lucrative growth opportunity for the market over the forecast period 2022-2029.

In Africa, the International Diabetes Federation (IDF) estimates that there were 19.4 million people with diabetes in 2019, and this number is expected to rise to 47 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Similarly, in South-East Asia, the IDF estimates that there were 88 million people with diabetes in 2019, and this number is expected to rise to 153 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Along with this, in the Western Pacific region, the IDF estimates that there were 159 million people with diabetes in 2019, and this number is expected to rise to 214 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). However, the high cost of Artificial Intelligence (AI) in Diabetes Management stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Artificial Intelligence (AI) in Diabetes Management Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North American market is the largest market for AI in diabetes management, primarily driven by the high prevalence of diabetes in the region, the availability of advanced healthcare infrastructure, and the adoption of digital technologies. The US is the largest market in North America, followed by Canada. The Asia Pacific market for AI in diabetes management is expected to grow at a significant rate, driven by factors such as the high prevalence of diabetes, increasing healthcare expenditure, and growing adoption of digital technologies. China, India, and Japan are the major markets in the Asia Pacific region.

Major market players included in this report are:

  • Abbott Laboratories
  • Medtronic
  • Dexcom
  • Glooko
  • Diabeloop
  • Bigfoot Biomedical
  • Beta Bionics
  • One Drop
  • Diabnext
  • Tidepool

Recent Developments in the Market:

  • In May 2021, Abbott Laboratories announced that it had received FDA clearance for its AI-powered algorithm, which is designed to help people with diabetes better manage their glucose levels using the FreeStyle Libre 2 CGM system.
  • In February 2021, Medtronic announced that it had received CE Mark approval for its AI-powered predictive insulin dosing algorithm, which is designed to help people with diabetes avoid hypoglycemia.
  • In January 2021, Dexcom announced that it had acquired TypeZero Technologies, a company that develops AI-powered diabetes management solutions, to enhance its product offerings in the AI diabetes management space.
  • In December 2020, Glooko announced that it had received FDA clearance for its AI-powered insulin titration solution, which is designed to help healthcare providers adjust insulin doses for people with diabetes more efficiently.

Global Artificial Intelligence (AI) in Diabetes Management Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Case-based Reasoning
  • Intelligent Data Analysis

By Application:

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Artificial Intelligence (AI) in Diabetes Management Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Artificial Intelligence (AI) in Diabetes Management Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Artificial Intelligence (AI) in Diabetes Management Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Artificial Intelligence (AI) in Diabetes Management Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Intelligence (AI) in Diabetes Management Market Dynamics

  • 3.1. Artificial Intelligence (AI) in Diabetes Management Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of diabetes
      • 3.1.1.2. Advancements in AI and machine learning
      • 3.1.1.3. Increasing demand for personalized healthcare
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Artificial Intelligence (AI) in Diabetes Management
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing adoption of wearable devices
      • 3.1.3.2. Advancements in AI and machine learning

Chapter 4. Global Artificial Intelligence (AI) in Diabetes Management Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Artificial Intelligence (AI) in Diabetes Management Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Type, Performance - Potential Analysis
  • 6.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 6.4.1. Case-based Reasoning
    • 6.4.2. Intelligent Data Analysis

Chapter 7. Global Artificial Intelligence (AI) in Diabetes Management Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Application, Performance - Potential Analysis
  • 7.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 7.4.1. Glucose Monitoring Devices
    • 7.4.2. Diagnostic Devices
    • 7.4.3. Insulin Delivery Devices
    • 7.4.4. Other Devices

Chapter 8. Global Artificial Intelligence (AI) in Diabetes Management Market, Regional Analysis

  • 8.1. Artificial Intelligence (AI) in Diabetes Management Market, Regional Market Snapshot
  • 8.2. North America Artificial Intelligence (AI) in Diabetes Management Market
    • 8.2.1. U.S. Artificial Intelligence (AI) in Diabetes Management Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Artificial Intelligence (AI) in Diabetes Management Market
  • 8.3. Europe Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.3.1. U.K. Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.2. Germany Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.3. France Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.4. Spain Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.5. Italy Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.6. Rest of Europe Artificial Intelligence (AI) in Diabetes Management Market
  • 8.4. Asia-Pacific Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.4.1. China Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.2. India Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.3. Japan Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.4. Australia Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.5. South Korea Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.6. Rest of Asia Pacific Artificial Intelligence (AI) in Diabetes Management Market
  • 8.5. Latin America Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.5.1. Brazil Artificial Intelligence (AI) in Diabetes Management Market
    • 8.5.2. Mexico Artificial Intelligence (AI) in Diabetes Management Market
  • 8.6. Rest of The World Artificial Intelligence (AI) in Diabetes Management Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Medtronic
    • 9.2.3. Dexcom
    • 9.2.4. Glooko
    • 9.2.5. Diabeloop
    • 9.2.6. Bigfoot Biomedical
    • 9.2.7. Beta Bionics
    • 9.2.8. One Drop
    • 9.2.9. Diabnext
    • 9.2.10. Tidepool

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption